171 related articles for article (PubMed ID: 33538035)
1. Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL-AF registry.
Krittayaphong R; Pumprueg S; Thongsri T; Wiwatworapan W; Choochunklin T; Kaewkumdee P; Yindeengam A;
Clin Cardiol; 2021 Mar; 44(3):415-423. PubMed ID: 33538035
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry.
Krittayaphong R; Boonyapiphat T; Wongvipaporn C; Sairat P;
Clin Interv Aging; 2021; 16():707-719. PubMed ID: 33953549
[TBL] [Abstract][Full Text] [Related]
3. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population, Data from the COOL-AF Thailand registry.
Chantrarat T; Krittayaphong R
Int J Cardiol; 2021 Jan; 323():90-99. PubMed ID: 32828960
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of patients with atrial fibrillation with and without diabetes: A propensity score matching of the COOL-AF registry.
Krittayaphong R; Aroonsiriwattana S; Ngamjanyaporn P; Patmuk T; Kaewkumdee P;
Int J Clin Pract; 2021 Nov; 75(11):e14671. PubMed ID: 34324768
[TBL] [Abstract][Full Text] [Related]
6. Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study.
Wang CL; Wu VC; Huang YT; Kuo CF; Chu PH; Chen YL; Wen MS; Chang SH
J Am Heart Assoc; 2019 May; 8(9):e012029. PubMed ID: 31020896
[TBL] [Abstract][Full Text] [Related]
7. Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.
Yoshimoto T; Toyoda K; Ihara M; Inoue H; Yamashita T; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Maruyama H; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T
Stroke; 2022 Aug; 53(8):2549-2558. PubMed ID: 35440169
[TBL] [Abstract][Full Text] [Related]
8. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.
Schnabel RB; Ameri P; Siller-Matula JM; Diemberger I; Gwechenberger M; Pecen L; Manu MC; Souza J; De Caterina R; Kirchhof P
Europace; 2023 Aug; 25(9):. PubMed ID: 37713182
[TBL] [Abstract][Full Text] [Related]
10. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study.
Yoshimura S; Koga M; Sato S; Todo K; Yamagami H; Kumamoto M; Itabashi R; Terasaki T; Kimura K; Yagita Y; Shiokawa Y; Kamiyama K; Okuda S; Okada Y; Takizawa S; Hasegawa Y; Kameda T; Shibuya S; Nagakane Y; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Fujita K; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yamaguchi Y; Kinoshita N; Matsuki T; Takasugi J; Tokunaga K; Higashida K; Homma K; Kario K; Arihiro S; Toyoda K;
Circ J; 2018 Jun; 82(7):1935-1942. PubMed ID: 29863095
[TBL] [Abstract][Full Text] [Related]
11. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry.
Krittayaphong R; Winijkul A; Methavigul K; Sairat P; Investigators COOLF
Cardiovasc Ther; 2022; 2022():5797257. PubMed ID: 35284003
[TBL] [Abstract][Full Text] [Related]
12. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P
Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
14. Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand.
Krittayaphong R; Kunjara-Na-Ayudhya R; Ngamjanyaporn P; Boonyaratavej S; Komoltri C; Yindeengam A; Sritara P; Lip GYH; For The Cool-Af Investigators
J Geriatr Cardiol; 2020 Oct; 17(10):612-620. PubMed ID: 33224180
[TBL] [Abstract][Full Text] [Related]
15. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics of Elderly Japanese Patients Aged ≥75 Years With Non-Valvular Atrial Fibrillation and a History of Stroke - ANAFIE Registry.
Kanemaru K; Yoshimoto T; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Kusano K; Toyoda K;
Circ J; 2020 Feb; 84(3):516-523. PubMed ID: 31983727
[TBL] [Abstract][Full Text] [Related]
17. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
18. Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.
Krittayaphong R; Pumprueg S; Ratanasumawong K; Sairat P; Lip GYH;
Clin Interv Aging; 2021; 16():1835-1846. PubMed ID: 34675498
[TBL] [Abstract][Full Text] [Related]
19. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
20. History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: results from the COOL-AF registry.
Krittayaphong R; Winijkul A; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Kaewcomdee P; Yindeengam A;
J Geriatr Cardiol; 2020 Apr; 17(4):184-192. PubMed ID: 32362916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
